receptor antagonists - Robuta Search

https://www.techtransfer.nih.gov/patent/e-290-1997-0-it-11 G-PROTEIN-COUPLED RECEPTOR ANTAGONISTS | Technology Transfer g protein receptor antagonists coupled technology transfer https://experts.umn.edu/en/publications/mineralocorticoid-receptor-antagonists-as-diuretics-can-congestiv/ Mineralocorticoid receptor antagonists as diuretics: Can congestive heart failure learn from liver... congestive heart failure mineralocorticoid receptor https://www.techtransfer.nih.gov/patent/e-285-2008-0-pct-02 Truncated (N)-Methanocarba Adenosine Derivatives As A3 Receptor Antagonists | Technology Transfer receptor antagonists adenosine derivatives https://gpe.wikipedia.org/wiki/Category:Glycine_receptor_antagonists Category:Glycine receptor antagonists - Wikipedia receptor antagonists category glycine wikipedia https://www.techtransfer.nih.gov/patent/e-028-2018-1-hk-08 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS | Technology Transfer receptor antagonists heterocyclic technology transfer https://adisinsight.springer.com/drugs/800086816?error=cookies_not_supported&code=f5485e31-97c3-4d19-a6a7-357f723e074c Calcitonin gene related peptide receptor antagonists - Pfizer - AdisInsight Pfizer is developing a calcitonin gene related peptide (CGRP) receptor antagonists for the treatment of undisclosed indication. Clinical development is underway receptor antagonists calcitonin gene related peptide https://www.techtransfer.nih.gov/patent/e-096-1998-0-ca-03 A3 Adenosine Receptor Antagonists | Technology Transfer adenosine receptor antagonists technology transfer https://research.birmingham.ac.uk/en/publications/qualitative-and-quantitative-simulation-of-androgen-receptor-anta/fingerprints/ Qualitative and quantitative simulation of androgen receptor antagonists: A case study of... androgen receptor qualitative quantitative simulation https://publications-cnrc.canada.ca/fra/voir/objet/?id=cb3fa8d6-5087-4aaf-a459-14da092fd504 Glutamate receptor antagonists for the treatment of cerebral ischemia - Archives des publications... Glutamate receptor antagonists for the treatment of cerebral ischemia receptor antagonists for the https://pubchem.ncbi.nlm.nih.gov/patent/EP-0479481-A3 Fibrinogen receptor antagonists - Patent EP-0479481-A3 - PubChem EP-0479481-A3 chemical patent summary. receptor antagonists fibrinogen patent pubchem https://adisinsight.springer.com/drugsafety/800007631?error=cookies_not_supported&code=f3455bba-8a92-4a33-b986-45317a2b7ed2 Comparable safety profiles of the H2-receptor antagonists - AdisInsight Despite the excellent safety record of the H2-receptor antagonists, cimetidine, ranitidine, famotidine and nizatidine, there remains a degree of confusion of the receptor antagonists comparable safety profiles https://www.techtransfer.nih.gov/patent/e-213-2015-0-us-05 TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS | Technology Transfer triazole derivatives receptor antagonists technology transfer https://experts.colorado.edu/display/meshid_D27.505.519.364 Endothelin Receptor Antagonists | CU Experts | CU Boulder endothelin receptor antagonists cu experts boulder https://www.techtransfer.nih.gov/patent/e-162-2023-0-pc-01 5-HT2B SEROTONIN RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE... receptor antagonists https://adisinsight.springer.com/drugs/800046251?error=cookies_not_supported&code=f8a517d3-0b19-46c6-bf4e-e31cbfe91a41 Research programme: mitochondrial angiotensin receptor antagonists - Gemstone Biotherapeutics -... Gemstone Biotherapeutics LLC was developing mitochondrial angiotensin receptor antagonists, utilising discoveries and technologies pioneered by researchers at research programme angiotensin receptor mitochondrial antagonists gemstone https://www.wikidata.org/wiki/Q40661137 Antigen analogs/MHC complexes as specific T cell receptor antagonists - Wikidata scientific article published on January 1994 mhc complexes t cell receptor antagonists antigen analogs https://adisinsight.springer.com/drugsafety/803930138?error=cookies_not_supported&code=20e212ed-875b-4c8a-a261-8eeefb4245c5 Programmed cell death 1 receptor antagonists - AdisInsight A patient receiving PD-1 inhibitor treatment experienced an atypical Herpes simplex-2 infection. cell death receptor antagonists programmed adisinsight https://www.techtransfer.nih.gov/patent/e-285-2008-0-de-08 A3 Adenosine Receptor Antagonists and Partial Agonists | Technology Transfer adenosine receptor antagonists partial technology transfer https://adisinsight.springer.com/drugsafety/803929520?error=cookies_not_supported&code=a2538174-c6a0-4393-894c-d0498f816163 Programmed cell death 1 receptor antagonists - AdisInsight Three patients with recurrent or metastatic maxillary sinus squamous cell carcinoma [ages and sexes not stated] were included among 15 individuals treated at cell death receptor antagonists programmed adisinsight https://www.sciencedaily.com/releases/2021/11/211108094235.htm Healing skin ischemia-reperfusion injuries with interleukin-36 receptor antagonists | ScienceDaily Skin wounds from ischemia-reperfusion injuries -- tissue damage caused by blood returning to tissues after a period of oxygen deprivation -- may not heal... receptor antagonists healing skin ischemia reperfusion https://pubmed.ncbi.nlm.nih.gov/28864614/ Somatostatin Receptor Antagonists for Imaging and Therapy Somatostatin receptor (sstr) scintigraphy for imaging and sstr analogs for treatment have been used for more than 20 y. An important improvement in recent... somatostatin receptor antagonists imaging therapy https://www.techtransfer.nih.gov/patent/e-213-2001-0-us-01 Anticancer Effects of a Novel Vitamin D Receptor Antagonists | Technology Transfer vitamin d receptor anticancer effects novel https://adisinsight.springer.com/drugsafety/803928660?error=cookies_not_supported&code=10916989-d921-423b-86d2-9c05024aeabe Programmed cell death 1 receptor antagonists - AdisInsight Five patients [ages and sexes not stated] treated with anti-programmed death-1 (PD-1) immune checkpoint inhibition [route, dosage and duration not stated] cell death receptor antagonists programmed adisinsight https://adisinsight.springer.com/drugsafety/803928181?error=cookies_not_supported&code=5772ef7a-ef63-41bf-afa9-b94bf346678c Immune checkpoint protein inhibitors/Programmed cell death 1 receptor antagonists - AdisInsight Fifty-nine adult patients [exact ages and sexes not stated] with cancer who received immune checkpoint inhibitors [dose, route and treatment duration not immune checkpoint cell death receptor antagonists protein inhibitors https://pmc.ncbi.nlm.nih.gov/articles/PMC17685/ SST3-selective potent peptidic somatostatin receptor antagonists - PMC A family of octapeptide derivatives of somatostatin cyclized via a disulfide bridge (des-AA1,2,4,5,12,13[d-2Nal8]-somatostatin-14, ODN-8) was identified that... somatostatin receptor selective potent antagonists pmc https://pubmed.ncbi.nlm.nih.gov/10416935/ Effects of muscarinic cholinergic receptor antagonists on postnatal eye growth of rhesus monkeys The drug treatment results implicate muscarinic receptors in postnatal eye growth regulation. Because of interanimal differences our data do not indicate... receptor antagonists https://www.techtransfer.nih.gov/patent/e-028-2018-1-ca-03 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS | Technology Transfer receptor antagonists heterocyclic technology transfer https://www.techtransfer.nih.gov/patent/e-051-2021-0-us-02 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS | Technology Transfer receptor antagonists heterocyclic technology transfer https://experts.colorado.edu/display/meshid_D27.505.519.625.240.300.500 Molecular Mechanisms of Pharmacological Action - GABA-A Receptor Antagonists | CU Experts | CU... receptor antagonists molecular mechanisms pharmacological action https://about.uq.edu.au/experts/project/45180 Characterisation of the effect of C5a receptor antagonists against the C5a-like receptor 2 (C5L2) |... of the receptor antagonists characterisation effect https://grillbert.substack.com/p/nmda-receptor-antagonists-a-bit-more/comments Comments - NMDA Receptor Antagonists: Slightly More than you Wanted to Know Insights from Memantine and Ketamine's divergent effects on the Brain nmda receptor antagonists more than comments slightly https://pubchem.ncbi.nlm.nih.gov/patent/EP-1146872-B1 Use of angiotensin ii receptor antagonists for treating acute myocardial infarction - Patent... EP-1146872-B1 chemical patent summary. acute myocardial infarction angiotensin ii receptor antagonists https://www.techtransfer.nih.gov/patent/e-285-2008-0-us-07 A3 Adenosine Receptor Antagonists And Partial Agonists | Technology Transfer adenosine receptor antagonists partial technology transfer https://www.cochrane.org/zh-hant/evidence/CD005449_adenosine-diphosphate-adp-receptor-antagonists-prevention-cardiovascular-disease-patients-type-2 Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in... receptor antagonists for the https://hsrc.himmelfarb.gwu.edu/gwhpubs/2138/ "Nonsteroidal mineralocorticoid receptor antagonists and cardiorenal ou" by Kevin Bryan Lo, Janani... The burden of adverse cardiorenal outcomes among patients with the trifecta of diabetes, heart failure (HF), and chronic kidney disease (CKD) remains high.... mineralocorticoid receptor https://cebs-ext.niehs.nih.gov/datasets/search/androgen_antagonists?casrn=30560-19-1 Evaluation of Androgen Receptor Antagonists | DTT Data Collections Guided Search androgen receptor data collections evaluation antagonists dtt https://nrc-publications.canada.ca/eng/view/object/?id=99b40bc6-8fda-4466-b27f-73323f96365a Excitotoxicity and glutamate receptor antagonists in Neuroprotection - NRC Publications Archive -... Excitotoxicity and glutamate receptor antagonists in Neuroprotection receptor antagonists excitotoxicity glutamate neuroprotection nrc https://www.techtransfer.nih.gov/patent/e-235-2008-0-us-01 P2Y1 RECEPTOR ANTAGONISTS | Technology Transfer receptor antagonists technology transfer https://adisinsight.springer.com/drugsafety/803927857?error=cookies_not_supported&code=e6eb660f-8439-4d74-98e7-67af8387a3e2 Disitamab vedotin/Programmed cell death 1 receptor antagonists - AdisInsight Twenty-nine patients with metastatic urothelial carcinoma, with a reported median age of 67 years and predominantly male (69%), received disitamab vedotin cell death receptor antagonists programmed adisinsight https://vivo.colorado.edu/display/pubid_52302 THE BENZODIAZEPINE RECEPTOR ANTAGONISTS FLUMAZENIL AND CGS8216 BLOCK THE ENHANCEMENT OF FEAR... receptor antagonists benzodiazepine flumazenil https://www.aafp.org/pubs/afp/issues/2003/0715/p354a.html Leukotriene Receptor Antagonists vs. Steroids | AAFP leukotriene receptor antagonists vs steroids aafp https://www.techtransfer.nih.gov/patent/e-310-2005-0-us-01 Prodrug Delivery Of A3 Adenosine Receptor Antagonists For Glaucoma Therapy | Technology Transfer adenosine receptor https://www.techtransfer.nih.gov/patent/e-213-2015-0-gb-08 TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS | Technology Transfer triazole derivatives receptor antagonists technology transfer https://experts.arizona.edu/en/publications/pharmacology-of-modality-specific-transient-receptor-potential-va/ Pharmacology of modality-specific transient receptor potential vanilloid-1 antagonists that do not... https://www.techtransfer.nih.gov/patent/e-226-1992-0-be-05 Methods for the Improvement of Cognition with Functional Antagonists of the Glycine NMDA Receptor... for the https://experts.arizona.edu/en/publications/transient-receptor-potential-vanilloid-1-antagonists-prevent-anes/ Transient Receptor Potential Vanilloid 1 Antagonists Prevent Anesthesia-induced Hypothermia and... transient receptor potential https://lnu.diva-portal.org/smash/record.jsf?pid=diva2:308572 Potency mismatch for behavioral and biochemical effects by dopamine receptor antagonists:... dopamine receptor potency mismatch behavioral https://vivo.colorado.edu/display/meshid_D27.505.519.625.850.850.200 Molecular Mechanisms of Pharmacological Action - Serotonin 5-HT2 Receptor Antagonists | CU Experts... https://profiles.wustl.edu/en/publications/design-and-synthesis-of-amidino-tyrosine-derivatives-as-non-pepti/ Design and synthesis of amidino-tyrosine derivatives as non-peptide fibrinogen receptor antagonists... https://www.techtransfer.nih.gov/patent/e-191-1993-3-de-05 A3 ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTS | Technology Transfer adenosine receptor agonists antagonists technology transfer https://pure.psu.edu/en/publications/potential-anxiogenic-effects-of-cannabinoid-cb1-receptor-antagoni/ Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats:... https://www.techtransfer.nih.gov/patent/e-253-1999-1-ep-08 USE OF A3 ADENOSINE RECEPTOR ANTAGONISTS IN THE MANUFACTURE OF A MEDICAMENT FOR REDUCING... https://www.techtransfer.nih.gov/patent/e-226-1992-0-ie-12 Methods for the Improvement of Cognition with Functional Antagonists of the Glycine NMDA Receptor... for the https://pmc.ncbi.nlm.nih.gov/articles/PMC10325868/ Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in Treatment of Insomnia... Insomnia is one of the major challenges in medical science nowadays as it leads to great socio-economic burden by impairing daytime function as well as the... https://research.monash.edu/en/publications/intravitreal-administration-of-endothelin-type-a-receptor-or-endo/ Intravitreal administration of endothelin type A receptor or endothelin type B receptor antagonists... type a administration receptor b antagonists https://pubchem.ncbi.nlm.nih.gov/bioassay/2357 AID 2357 - SAR Analysis of Antagonists of the DOR Receptor using an Image-Based Assay - PubChem BioAssay record AID 2357 submitted by Sanford-Burnham Center for Chemical Genomics: SAR Analysis of Antagonists of the DOR Receptor using an Image-Based Assay. https://pubmed.ncbi.nlm.nih.gov/30404914/ Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists Drugs that treat chronic obstructive pulmonary disease by antagonizing the M3 muscarinic acetylcholine receptor (M3R) have had a significant effect on health,... structure guided development selective acetylcholine https://www.techtransfer.nih.gov/patent/e-067-2010-0-ep-06 Inverse Agonists And Neutral Antagonists For the TSH Receptor | Technology Transfer for the tsh receptor inverse agonists neutral https://www.techtransfer.nih.gov/patent/e-191-1993-3-it-09 A3 ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTS | Technology Transfer adenosine receptor agonists antagonists technology transfer https://pmc.ncbi.nlm.nih.gov/articles/PMC3926345/ Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases - PMC Acetylcholine (neuronal and non-neuronal origin) regulates bronchoconstriction, and mucus secretion. It has an inflammatory effect by inducing attraction,... https://www.techtransfer.nih.gov/patent/e-121-1993-0-pct-02 8-SUBSTITUTED 1,3,7-TRIALKYL-XANTHINE DERIVATIVES AS A2-SELECTIVE ADENOSINE RECEPTOR ANTAGONISTS |... https://oru.diva-portal.org/smash/record.jsf?faces-redirect=true&language=sv&searchType=SIMPLE&query=&af=%5B%5D&aq=%5B%5B%5D%5D&aq2=%5B%5B%5D%5D&aqe=%5B%5D&pid=diva2%3A1553229&noOfRows=50&sortOrder=author_sort_asc&sortOrder2=title_sort_asc&onlyFullText=false&sf=all In silico and in vitro assessment of androgen receptor antagonists in silico androgen receptor vitro assessment antagonists https://pubchem.ncbi.nlm.nih.gov/bioassay/1224840 AID 1224840 - qHTS assay to identify small molecule antagonists of the estrogen related receptor... BioAssay record AID 1224840 submitted by Tox21: qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the... https://pubchem.ncbi.nlm.nih.gov/patent/US-2008287398-A1 Cold menthol receptor-1 antagonists - Patent US-2008287398-A1 - PubChem US-2008287398-A1 chemical patent summary. patent us cold menthol receptor antagonists https://pubchem.ncbi.nlm.nih.gov/bioassay/602448 AID 602448 - qHTS for antagonists of the Thyroid Stimulation Hormone Receptor: Hit Validation with... BioAssay record AID 602448 submitted by National Center for Advancing Translational Sciences (NCATS): qHTS for antagonists of the Thyroid Stimulation Hormone... https://www.techtransfer.nih.gov/patent/e-067-2010-0-au-03 Inverse Agonists And Neutral Antagonists For the TSH Receptor | Technology Transfer for the tsh receptor inverse agonists neutral https://www.techtransfer.nih.gov/news/licensing-collaboration-opportunity-for-next-gen-5-ht-2b-serotonin-receptor-antagonists-for Licensing/Collaboration Opportunity for Next-Gen 5-HT-2B Serotonin-Receptor Antagonists for... collaboration opportunity next gen https://pubchem.ncbi.nlm.nih.gov/bioassay/1259247 AID 1259247 - qHTS assay to identify small molecule antagonists of the androgen receptor (AR)... BioAssay record AID 1259247 submitted by Tox21: qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA... https://pubchem.ncbi.nlm.nih.gov/bioassay/2836 AID 2836 - SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay -... BioAssay record AID 2836 submitted by Sanford-Burnham Center for Chemical Genomics: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an... https://www.techtransfer.nih.gov/patent/e-067-2010-0-in-07 Inverse Agonists And Neutral Antagonists For the TSH Receptor | Technology Transfer for the tsh receptor inverse agonists neutral https://pubmed.ncbi.nlm.nih.gov/17479101/?dopt=Abstract Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists The identification of the antigen recognition receptors for innate immunity, most notably the Toll-like receptors, has sparked great interest in therapeutic... innate immunity https://www.techtransfer.nih.gov/patent/e-053-2016-0-us-01 Dopamine D3 Receptor Selective Antagonists/Partial Agonists; Method of Making; and Use Thereof |... https://pubmed.ncbi.nlm.nih.gov/33682527/ Pilot study of tolerability and safety of opioid receptor antagonists as novel therapies for... ClinicalTrials.gov identifier: NCT03278886. https://www.ncbi.nlm.nih.gov/Structure/pdb/5FQS 5FQS: Selective estrogen receptor downregulator antagonists: Tetrahydroisoquinoline phenols 3 ESTROGEN RECEPTOR(E)-3-[4-(6-HYDROXY-2-ISOBUTYL-1-METHYL-3,4-DIHYDROISOQUINOLIN-1-YL)PHENYL]PROP-2-ENOIC ACID estrogen receptor selective antagonists phenols https://www.techtransfer.nih.gov/patent/e-323-2002-0-gb-05 USE OF A3 ADENOSINE RECEPTOR ANTAGONISTS IN THE MANUFACTURE OF A MEDICAMENT FOR REDUCING... https://pubmed.ncbi.nlm.nih.gov/28806222/ Transient Receptor Potential Vanilloid 1 Antagonists Prevent Anesthesia-induced Hypothermia and... These studies demonstrate that transient receptor potential vanilloid 1 antagonists prevent anesthesia-induced hypothermia and decrease opioid dose... transient receptor potential https://pubchem.ncbi.nlm.nih.gov/bioassay/867 AID 867 - Counterscreen for antagonists of galanin receptor 2 (GalR2): a cell-based high-throughput... BioAssay record AID 867 submitted by The Scripps Research Institute Molecular Screening Center: Counterscreen for antagonists of galanin receptor 2 (GalR2): a... https://bonndoc.ulb.uni-bonn.de/xmlui/handle/20.500.11811/10805 Irreversible Antagonists for the Adenosine A2B Receptor for the irreversible antagonists adenosine receptor